Composite angioimmunoblastic T-cell and diffuse large B-cell lymphoma

Hematol Oncol Stem Cell Ther. 2015 Sep;8(3):136-7. doi: 10.1016/j.hemonc.2015.04.006. Epub 2015 Apr 28.

Authors

Anna Alperovich¹, Panagiotis J Vlachostergios², Adam Binder³, Andrew H Oliff⁴, Rajeev L Balmiki⁵, Francois Dufresne¹

Affiliations

¹ Department of Medicine, Lutheran Medical Center, Brooklyn, NY, USA.
² Department of Medicine, Lutheran Medical Center, Brooklyn, NY, USA. Electronic address: pvlachostergios@lmcmc.com.
³ Department of Medicine, Icahn School of Medicine, Mount Sinai Medical Center, New York, NY, USA.
⁴ Department of Pathology and Laboratory Medicine, Lutheran Medical Center, Brooklyn, NY, USA.
⁵ Department of Hematology/Oncology, Lutheran Medical Center, Brooklyn, NY, USA.

PMID: 25953233
DOI: 10.1016/j.hemonc.2015.04.006

No abstract available

Publication types

Case Reports

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Biopsy
CD3 Complex / metabolism
Echocardiography
Fatal Outcome
Female
Humans
Hypertension / complications
Lymphocytes / cytology
Lymphoma, Large B-Cell, Diffuse / drug therapy
Lymphoma, Large B-Cell, Diffuse / immunology*
Lymphoma, Large B-Cell, Diffuse / pathology
Lymphoma, T-Cell / drug therapy
Lymphoma, T-Cell / immunology*
Lymphoma, T-Cell / pathology
Middle Aged
Pericardial Effusion
Polymerase Chain Reaction
Prognosis
Tomography, X-Ray Computed

Substances

CD3 Complex